Your browser doesn't support javascript.
loading
Correction for Ferrero et al., "Antibody-Based Inhibition of Pathogenic New World Hemorrhagic Fever Mammarenaviruses by Steric Occlusion of the Human Transferrin Receptor 1 Apical Domain".
Ferrero, Sol; Flores, Maria D; Short, Connor; Vazquez, Cecilia A; Clark, Lars E; Ziegenbein, James; Zink, Samantha; Fuentes, Daniel; Payes, Cristian; Batto, María V; Collazo, Michael; García, Cybele C; Abraham, Jonathan; Cordo, Sandra M; Rodriguez, Jose A; Helguera, Gustavo.
Afiliação
  • Ferrero S; Laboratory of Pharmaceutical Biotechnology, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina.
  • Flores MD; Department of Chemistry and Biochemistry, UCLA-DOE Institute for Genomics and Proteomics, University of California Los Angeles, Los Angeles, California, USA.
  • Short C; Department of Chemistry and Biochemistry, UCLA-DOE Institute for Genomics and Proteomics, University of California Los Angeles, Los Angeles, California, USA.
  • Vazquez CA; Laboratorio de Virología, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (UBA), IQUIBICEN, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)-UBA, Ciudad Universitaria, Buenos Aires, Argentina.
  • Clark LE; IQUIBICEN, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)-UBA, Ciudad Universitaria, Buenos Aires, Argentina.
  • Ziegenbein J; Department of Microbiology, Blavatnik Institute, Harvard Medical Schoolgrid.471403.5, Boston, Massachusetts, USA.
  • Zink S; Department of Chemistry and Biochemistry, UCLA-DOE Institute for Genomics and Proteomics, University of California Los Angeles, Los Angeles, California, USA.
  • Fuentes D; Department of Chemistry and Biochemistry, UCLA-DOE Institute for Genomics and Proteomics, University of California Los Angeles, Los Angeles, California, USA.
  • Payes C; Department of Chemistry and Biochemistry, UCLA-DOE Institute for Genomics and Proteomics, University of California Los Angeles, Los Angeles, California, USA.
  • Batto MV; Laboratory of Pharmaceutical Biotechnology, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina.
  • Collazo M; Laboratory of Pharmaceutical Biotechnology, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina.
  • García CC; Department of Biological Chemistry and Department of Chemistry and Biochemistry, University of California Los Angeles, Howard Hughes Medical Institute, UCLA-DOE Institute for Genomics and Proteomics, Los Angeles, California, USA.
  • Abraham J; Laboratorio de Virología, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (UBA), IQUIBICEN, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)-UBA, Ciudad Universitaria, Buenos Aires, Argentina.
  • Cordo SM; IQUIBICEN, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)-UBA, Ciudad Universitaria, Buenos Aires, Argentina.
  • Rodriguez JA; Department of Microbiology, Blavatnik Institute, Harvard Medical Schoolgrid.471403.5, Boston, Massachusetts, USA.
  • Helguera G; Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
J Virol ; 96(4): e0216321, 2022 Feb 23.
Article em En | MEDLINE | ID: mdl-35195450
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Argentina
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Argentina